New injection aims to strengthen weakened bones in rare disorder
NCT ID NCT05509595
Summary
This study tested whether a drug called burosumab could safely raise low phosphate levels in people with fibrous dysplasia, a condition that weakens bones. Twelve participants aged 1 and older received injections of the drug at home once or twice a month for 48 weeks. Researchers checked if the treatment improved phosphate levels, bone health, pain, and mobility.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROUS DYSPLASIA OF BONE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.